FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2946335051> ?p ?o ?g. }

• W2946335051 endingPage "6240" @default.
• W2946335051 startingPage "6223" @default.
• W2946335051 abstract "A series of pyrazolopyrimidine inhibitors of IRAK4 were developed from a high-throughput screen (HTS). Modification of an HTS hit led to a series of bicyclic heterocycles with improved potency and kinase selectivity but lacking sufficient solubility to progress in vivo. Structure-based drug design, informed by cocrystal structures with the protein and small-molecule crystal structures, yielded a series of dihydrobenzofurans. This semisaturated bicycle provided superior druglike properties while maintaining excellent potency and selectivity. Improved physicochemical properties allowed for progression into in vivo experiments, where lead molecules exhibited low clearance and showed target-based inhibition of IRAK4 signaling in an inflammation-mediated PK/PD mouse model." @default.
• W2946335051 created "2019-05-29" @default.
• W2946335051 creator A5005055708 @default.
• W2946335051 creator A5010464799 @default.
• W2946335051 creator A5014679061 @default.
• W2946335051 creator A5016185774 @default.
• W2946335051 creator A5016365617 @default.
• W2946335051 creator A5020748223 @default.
• W2946335051 creator A5022225535 @default.
• W2946335051 creator A5022853919 @default.
• W2946335051 creator A5027966349 @default.
• W2946335051 creator A5038639667 @default.
• W2946335051 creator A5046103700 @default.
• W2946335051 creator A5046989492 @default.
• W2946335051 creator A5047497607 @default.
• W2946335051 creator A5049254683 @default.
• W2946335051 creator A5051487266 @default.
• W2946335051 creator A5056844262 @default.
• W2946335051 creator A5063108526 @default.
• W2946335051 creator A5063674230 @default.
• W2946335051 creator A5066158150 @default.
• W2946335051 creator A5066900396 @default.
• W2946335051 creator A5068327587 @default.
• W2946335051 creator A5075146461 @default.
• W2946335051 creator A5081153795 @default.
• W2946335051 creator A5087073105 @default.
• W2946335051 creator A5088627206 @default.
• W2946335051 creator A5091399636 @default.
• W2946335051 date "2019-05-13" @default.
• W2946335051 modified "2023-09-23" @default.
• W2946335051 title "Development of Potent and Selective Pyrazolopyrimidine IRAK4 Inhibitors" @default.
• W2946335051 cites W2005214673 @default.
• W2946335051 cites W2018185552 @default.
• W2946335051 cites W2059555956 @default.
• W2946335051 cites W2074274985 @default.
• W2946335051 cites W2082143240 @default.
• W2946335051 cites W2082549235 @default.
• W2946335051 cites W2093508027 @default.
• W2946335051 cites W2096095251 @default.
• W2946335051 cites W2106232004 @default.
• W2946335051 cites W2121830340 @default.
• W2946335051 cites W2128124948 @default.
• W2946335051 cites W2133892659 @default.
• W2946335051 cites W2137540618 @default.
• W2946335051 cites W2141528038 @default.
• W2946335051 cites W2212076220 @default.
• W2946335051 cites W2242410523 @default.
• W2946335051 cites W2315844347 @default.
• W2946335051 cites W2324201740 @default.
• W2946335051 cites W2355876222 @default.
• W2946335051 cites W2562855125 @default.
• W2946335051 cites W2613042274 @default.
• W2946335051 cites W2755753508 @default.
• W2946335051 cites W2796419445 @default.
• W2946335051 cites W2806532950 @default.
• W2946335051 doi "https://doi.org/10.1021/acs.jmedchem.9b00439" @default.
• W2946335051 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31082230" @default.
• W2946335051 hasPublicationYear "2019" @default.
• W2946335051 type Work @default.
• W2946335051 sameAs 2946335051 @default.
• W2946335051 citedByCount "18" @default.
• W2946335051 countsByYear W29463350512019 @default.
• W2946335051 countsByYear W29463350512020 @default.
• W2946335051 countsByYear W29463350512021 @default.
• W2946335051 countsByYear W29463350512022 @default.
• W2946335051 countsByYear W29463350512023 @default.
• W2946335051 crossrefType "journal-article" @default.
• W2946335051 hasAuthorship W2946335051A5005055708 @default.
• W2946335051 hasAuthorship W2946335051A5010464799 @default.
• W2946335051 hasAuthorship W2946335051A5014679061 @default.
• W2946335051 hasAuthorship W2946335051A5016185774 @default.
• W2946335051 hasAuthorship W2946335051A5016365617 @default.
• W2946335051 hasAuthorship W2946335051A5020748223 @default.
• W2946335051 hasAuthorship W2946335051A5022225535 @default.
• W2946335051 hasAuthorship W2946335051A5022853919 @default.
• W2946335051 hasAuthorship W2946335051A5027966349 @default.
• W2946335051 hasAuthorship W2946335051A5038639667 @default.
• W2946335051 hasAuthorship W2946335051A5046103700 @default.
• W2946335051 hasAuthorship W2946335051A5046989492 @default.
• W2946335051 hasAuthorship W2946335051A5047497607 @default.
• W2946335051 hasAuthorship W2946335051A5049254683 @default.
• W2946335051 hasAuthorship W2946335051A5051487266 @default.
• W2946335051 hasAuthorship W2946335051A5056844262 @default.
• W2946335051 hasAuthorship W2946335051A5063108526 @default.
• W2946335051 hasAuthorship W2946335051A5063674230 @default.
• W2946335051 hasAuthorship W2946335051A5066158150 @default.
• W2946335051 hasAuthorship W2946335051A5066900396 @default.
• W2946335051 hasAuthorship W2946335051A5068327587 @default.
• W2946335051 hasAuthorship W2946335051A5075146461 @default.
• W2946335051 hasAuthorship W2946335051A5081153795 @default.
• W2946335051 hasAuthorship W2946335051A5087073105 @default.
• W2946335051 hasAuthorship W2946335051A5088627206 @default.
• W2946335051 hasAuthorship W2946335051A5091399636 @default.
• W2946335051 hasBestOaLocation W29463350512 @default.
• W2946335051 hasConcept C100687433 @default.
• W2946335051 hasConcept C112887158 @default.
• W2946335051 hasConcept C118792377 @default.
• W2946335051 hasConcept C150903083 @default.

• next